Garteiz MD, Jorge DL, Weber SA, Carbó RR, Bravo TC

Language: Spanish
References: 22
Page: 184-190
PDF size: 300.03 Kb.

ABSTRACT

Special concern has recently rised on the posibility of sowing and diseminating benign or malignant tissue into the abdominal cavity after uterine morcellation in laparoscopic hysterectomies. Food and Drug Administration (FDA) issued a series of safety recomendations based on the following facts; The risk that a patient submited to a histerectomy or myomectomy for a suspected benign myomatosis of having an unsuspected sarcoma is 1:350 cases and a leiomyosarcoma is 1:500 cases. The chances of peritoneal dissemination and increasing it´s cancer staging (FIGO/III or IV) after the use of morcellation is up to 25-65%. Those patients with unsuspected sarcoma that are submitted to morcellation can have a lower life expectancy and a less malignancy free life time compared with those in whom morcellation was not performed. This paper reviewes bibliografic data that supports FDA recommendations on regards to the use of uterine morcellation and its relevance after the increase in the incidence of parasitic myoma as a clinical entity, emphasising on the hystopathologic approach needed in order to verify the presence or abscence of malignancy.

REFERENCES

1. Giovanardi G, Oden S, Khalil H, Marpeau L, Seracchioli R, Roman H. Parasitic myomas due to laparoscopic intraabdominal morcellation. CRSLS. 2013; 1-7.

2. Cucinella G, Granese R, Calagna G, Somigliana E, Perino A. Parasitic myomas after laparoscopic surgery: an emerging complication in the use of morcellator? Description of four cases. Fertility Steril. 2011; 96: 90-96.

3. La Coursiere DY, Kennedy J, Hoffmann CP. Retained fragments after total laparoscopic hysterectomy. J Minim Invasive Gynecol. 2005; 12: 67-69.

4. Kelly HA, Cullen TS. Myomata of the uterus. Philadelphia: WB Saunders; 1909. p. 13.

5. Temizkan O, Erenel H, Arici B, Asicioglu O. A case of parasitic myoma 4 years after laparoscopic myomectomy. J Min Access Surg. 2014; 10: 202-203.

6. Larrain D, Rabischong B, Khoo CK, Botchorishvili R, Canis M, Mage G. “Iatrogenic” parasitic myomas: unusual late complication of laparoscopic morcellation procedures. J Minim Invasive Gynecol. 2010; 17: 719-724.

7. Food and Drug Administration Executive Summary Prepared for the July 10-14, 2014 meeting of the Obstetrics and Gynecology Devices Advisory Committee. Power morcellation and occult malignancy in gynecologic surgery: a special report. American College of Obstetricians and Gynecologists. 2014. pp. 1-65.

8. Ostrzenski A. Uterine leiomyoma particle growing in an abdominal wall incision after laparoscopic retrieval. Obstet Gynecol. 1997; 89: 853-854.

9. Sepilian V, Della Badia C. Iatrogenic endometriosis caused by uterine morcellation during a supracervical hysterectomy. Obstet Gynecol. 2003; 102: 1125-1127.

10. Pezzuto A, Pontrelli G, Ceccaroni M, Ferrari B, Nardelli GB, Minelli L. Case report of asymptomatic peritoneal leiomyomas. Eur J Obstet Gynecol Reprod Biol. 2010; 148: 205-206.

11. Paul PG, Koshy AK. Multiple peritoneal parasitic myomas after laparoscopic myomectomy and morcellation. Fertil Steril. 2006; 85: 492-493.

12. Epstein JH, Nejat EJ, Tsai T. Parasitic myomas after laparoscopic myomectomy: case report. Fertil Steril. 2009; 91: 932.e13-14.

13. Condous G, Bignardi T, Alhamdan D, Van Calster B, Van Huffel S, Timmerman D et al. What determines the need to morcellate the uterus during total laparoscopic hysterectomy? J Minim Invasive Gynecol. 2009; 16: 52-55.

14. Ridolfi C, Pasini G, Drudi F, Barzotti E, Santelmo C, Polselli A et al. Long lasting clinical response to chemotherapy for advanced uterine leiomyosarcoma: a case report. J Med Case Rep. 2013; 7: 29.

15. Rawish K, Fadare O. Dedifferentiated leiomyosarcoma of the uterus with heterologous elements: A potential diagnostic pitfall. Case Rep Obstet Gynecol. 2012; 2012: 534634.

16. Ip PP, Tse KY, Tam KF. Uterine smooth muscle tumors other than the ordinary leiomyomas and leiomyosarcomas: A review of selected variants with emphasis on recent advances and unusual morphology that may cause concern for malignancy. Adv Anat Pathol. 2010; 17: 91-112.

17. Billings SD, Folpe AL, Weiss SW. Do leiomyomas of deep soft tissue exist? An analysis of highly differentiated smooth muscle tumors of deep soft tissuesupporting two distinct subtypes. Am J Surg Path. 2001; 25: 1134-1142.

18. Carvalho F, Carvalho JP, Pereira RMA, Ceccato PV, Lacordia R, Baracat EC. Leiomyomatosis peritonealis disseminata associated with endometriosis and multiple uterus-like mass: report of two cases. Clin Med Insights Case Rep. 2012; 5: 63-68.

19. García M, Viciano V, Aguiló J, Torro J, Medrano J, Ferri RJ y cols. Leiomiomatosis peritoneal diseminada. A propósito de un caso y revisión bibliográfica. Cir Esp. 2001; 69: 610-612.

20. Paal E, Miettinen M. Retroperitoneal leiomyomas: a clinicopathologic and immunohistochemical study of 56 cases with a comparison to retroperitoneal leiomyosarcomas. Am J Surg Path. 2001; 25: 1355-1363.

21. Rivard C, Salhadar A, Kenton K. New challenges in detecting, grading and staging endometrial cancer after uterine morcellation. J Minim Invasive Gynecol. 2012; 19: 313-316.

22. Wright JD, Chen L, Burke WM, Hou JY, Tergas AI, Ananth CV et al. Trends in use and outcomes of women undergoing hysterectomy with electric power morcellation. JAMA. 2016; 316: 877-878.